HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A population-based serosurveillance of syphilis in Costa Rica.

Abstract
As part of a case-control study to investigate the high incidence of cervical cancer in Costa Rican women, the seroprevalence of the treponematoses, in particular, syphilis was determined. In each age group, women with a history of two or more sex partners were two to four times more likely to be seroreactive in tests for syphilis than women with zero or one sex partner. The highest percentage of reactive results in the microhemagglutination assay for antibodies to Treponema pallidum (MHA-TP) was seen in samples from women aged 50-59 who had had two or more lifetime partners (23.8%). Three observations from our study support reactivity due to syphilis rather than yaws or pinta: (1) a similar percent of reactive rapid plasma reagin (RPR) card test results among MHA-TP reactors in the two age groups of women who were surveyed (42 vs. 49%) was observed; (2) women who were seroreactive in the MHA-TP had multiple risk factors for STD [low socioeconomic status (9.4%), urban residence (22.8%), first intercourse under 16 years of age (14.1%), and multiple sex partners (26.3%)], and (3) only sexually experienced women had reactive results in the MHA-TP test.
AuthorsS A Larsen, M W Oberle, J M Sanchez-Braverman, L Rosero-Bixby, K M Vetter
JournalSexually transmitted diseases (Sex Transm Dis) 1991 Apr-Jun Vol. 18 Issue 2 Pg. 124-8 ISSN: 0148-5717 [Print] United States
PMID1862461 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Topics
  • Adult
  • Age Factors
  • Case-Control Studies
  • Costa Rica (epidemiology)
  • Educational Status
  • Female
  • Humans
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Sexual Partners
  • Socioeconomic Factors
  • Syphilis (epidemiology)
  • Syphilis Serodiagnosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: